Journal of Hepatology
Volume 48 , Pages S2-S19 , 2008

Hepatitis B: Reflections on the current approach to antiviral therapy

  • Fabien Zoulim

      Affiliations

    • INSERM, U871, 69003 Lyon, France
    • Université Lyon 1, IFR62 Lyon-Est, 69008 Lyon, France
    • Hospices Civils de Lyon, Hôtel Dieu, Liver Unit, 69002 Lyon, France
    • ,
  • Robert Perrillo

      Affiliations

    • Hepatology Division, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75206, USA
    • Corresponding Author InformationCorresponding author.

☆ F. Zoulim declares that he is a consultant for: Gilead Sciences, Bristol Myers Squibb and Novartis. R.P. Perrillo declares that he receives funding from Novartis and Bristol Myers Squibb for clinical research in hepatitis B. This study was not funded by any of the above.

PII: S0168-8278(08)00057-3

doi: 10.1016/j.jhep.2008.01.011

Journal of Hepatology
Volume 48 , Pages S2-S19 , 2008

Article Tools

* Image Usage & Resolution